BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6318634)

  • 1. Metastatic insulinoma with long survival and glucagonoma syndrome.
    D'Arcangues CM; Awoke S; Lawrence GD
    Ann Intern Med; 1984 Feb; 100(2):233-5. PubMed ID: 6318634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case with glucagonoma syndrome--endocrine and metabolic studies.
    Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
    Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
    Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
    Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucagonoma without the glucagonoma syndrome].
    Morosini M; Sommo M; Marconi R
    Minerva Chir; 1985 May; 40(10):707-9. PubMed ID: 2993957
    [No Abstract]   [Full Text] [Related]  

  • 5. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
    Murata E; Tashiro S; Hiraoka T
    Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic insulinoma: a case report and autopsy series.
    Kishi S; Sakamoto K; Mori M; Isogawa A; Shiba T
    Diabetes Res Clin Pract; 2012 Dec; 98(3):445-51. PubMed ID: 23084041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
    Moattari AR; Cho K; Vinik AI
    Surgery; 1990 Sep; 108(3):581-7. PubMed ID: 2168587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and metabolic aspects of glucagonoma.
    Leichter SB
    Medicine (Baltimore); 1980 Mar; 59(2):100-13. PubMed ID: 6987481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
    Ellison EC; O'Dorisio TM; Benson GD
    Am J Surg; 1986 Jun; 151(6):668-75. PubMed ID: 2872829
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors.
    Wermers RA; Fatourechi V; Kvols LK
    Mayo Clin Proc; 1996 Nov; 71(11):1030-8. PubMed ID: 8917287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lowering of the glycemic threshold in pituitary and adrenal response to hyperglycemia in insulinoma].
    Grimaldi A; Bosquet F; Sachon C; Davidoff P; Landault C; Zoghbi F; Duet M
    Diabete Metab; 1989; 15(4):209. PubMed ID: 2553509
    [No Abstract]   [Full Text] [Related]  

  • 12. Qualitative abnormality of insulin secretion in a case with insulinoma.
    Harano Y; Kohama M; Araki N; Sakamoto A; Hoshi M
    Endocrinol Jpn; 1975 Apr; 22(2):175-80. PubMed ID: 168060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization.
    Nesović M; Cirić J; Radojković S; Zarković M; Durović M
    J Endocrinol Invest; 1992; 15(7):543-7. PubMed ID: 1447492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metastatic liver disease].
    Privezentseva TV
    Vestn Rentgenol Radiol; 1985; (4):78-80. PubMed ID: 3000065
    [No Abstract]   [Full Text] [Related]  

  • 15. Are elevated pancreatic polypeptide levels in patients with insulinoma secondary to hypoglycaemia?
    Nelson RL; Service FJ; Ilstrup DM; Go VL
    Lancet; 1980 Sep; 2(8196):659-61. PubMed ID: 6106782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radio-frequency ablation for symptom control in a patient with metastatic pancreatic insulinoma.
    Scott A; Hinwood D; Donnelly R
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):557-9. PubMed ID: 11966750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995).
    Kvols LK; Buck M; Moertel CG; Schutt AJ; Rubin J; O'Connell MJ; Hahn RG
    Ann Intern Med; 1987 Aug; 107(2):162-8. PubMed ID: 2886085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of hypoglycemia in insulinoma patients: suppression of hepatic glucose production by insulin.
    Rizza RA; Haymond MW; Verdonk CA; Mandarino LJ; Miles JM; Service FJ; Gerich JE
    Diabetes; 1981 May; 30(5):377-81. PubMed ID: 6262168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between blood pressure and insulin in patients with insulinoma.
    Tsutsu N; Nunoi K; Kodama T; Nomiyama R; Iwase M; Fujishima M
    J Hypertens; 1990 May; 8(5):479-82. PubMed ID: 2163424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive insulinoma with bone metastases.
    Hesdorffer CS; Stoopler M; Javitch J
    Am J Clin Oncol; 1989 Dec; 12(6):498-501. PubMed ID: 2556011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.